Concepedia

Martina Rahmeh

MR

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

2006

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

München Klinik

Mayo Clinic

University of California, Los Angeles

Martina Rahmeh is an author at Ludwig-Maximilians-Universität München specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2006–2021

13

Publications

13

Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells

Gottfried E. Konecny, Mark D. Pegram, Natarajan Venkatesan et al. · Cancer Research · 2006 · 904 citations

, , +11

Nelfinavir and bortezomib inhibit mTOR activity via ATF4‐mediated sestrin‐2 regulation

Ansgar Brüning, Martina Rahmeh, Klaus Friese · Molecular Oncology · 2013 · 138 citations · Full text

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells

Gottfried E. Konecny, Natarajan Venkatesan, Guangen Yang et al. · British Journal of Cancer · 2008 · 110 citations · Full text

Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis

Ansgar Brüning, Petra Burger, Marianne Vogel et al. · Cancer Biology & Therapy · 2009 · 65 citations · Full text

Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis

Ansgar Brüning, Petra Burger, Marianne Vogel et al. · Investigational New Drugs · 2008 · 43 citations

, , +10

1–5 of 13